Disclosure Plus

Hyper Corporation Withdraws Plan for a Paid-in Capital Increase

Kwon Oh Seok
2026-08-27 16:30:39
[Edaily Reporter Kwon Oh Seok ] Hyper Corporation(065650), which had been pursuing a rights offering followed by a public offering of unsubscribed shares to raise operating funds, announced on the 27th that it is withdrawing its capital increase plan. The company explained, “During the public offering process, the Financial Supervisory Service requested corrections and additional reviews, which prolonged the capital increase process. We determined that this could cause confusion among existing shareholders and new investors.” Previously, the company had announced plans for a capital increase of approximately 20 billion won.

Economy

Corporation

IT·Science

Economy

Shifting from Short-Term to Medium- and Long-Term... Appeal of Commercial Paper as a Funding Source Plummets

Fluctuations in credit spreads serve as an indicator of investor sentiment and capital flows in the corporate bond market. “Credit Signal” provides an intuitive analysis of the market’s overall trends…
2026-10-23 17:57:04

Corporation

Jeong Yong-jin Starts by Replacing E-MART Co., Ltd.’s CEO… Appoints Entire Executive Team in Their 40s

Shinsegae Co.,Ltd Chairman Chung Yong-jin is returning to the forefront of management at E-MART Co., Ltd.(139480). Unlike in 2013, when he stepped down as a registered director and entrusted the busin…
2026-10-23 14:55:06

IT·Science

HANALL BIOPHARMA CO.,LTD’s ‘Batoclimab’ Receives First New Drug Approval in China Nine Years After Technology Export

“Batoclimab,” a treatment for autoimmune diseases developed by HANALL BIOPHARMA CO.,LTD(009420), has received new drug approval in China. This comes approximately nine years after the company licensed…
2026-10-23 21:05:02